These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Pathophysiology and diagnostic value of urinary trypsin inhibitors. Pugia MJ; Lott JA Clin Chem Lab Med; 2005; 43(1):1-16. PubMed ID: 15653436 [TBL] [Abstract][Full Text] [Related]
25. Serum trypsin inhibitory capacity in normal pregnancy and gestational diabetes mellitus. Yaghmaei M; Hashemi M; Shikhzadeh A; Mokhtari M; Niazi A; Ghavami S Diabetes Res Clin Pract; 2009 Jun; 84(3):201-4. PubMed ID: 19344972 [TBL] [Abstract][Full Text] [Related]
26. Increased urinary orosomucoid excretion: a proposed marker for inflammation and endothelial dysfunction in patients with type 2 diabetes. Christiansen MS; Iversen K; Larsen CT; Goetze JP; Hommel E; Mølvig J; Pedersen BK; Magid E; Feldt-Rasmussen B Scand J Clin Lab Invest; 2009; 69(2):272-81. PubMed ID: 18972260 [TBL] [Abstract][Full Text] [Related]
27. Urinary trypsin inhibitor and urokinase activities in renal diseases. Toki N; Sumi H Acta Haematol; 1982; 67(2):109-13. PubMed ID: 6801891 [TBL] [Abstract][Full Text] [Related]
28. Automated measurement of trypsin inhibitor in urine with a centrifugal analyzer: comparison with other acute phase reactants. Kuwajima S; Matsui T; Kitahashi S; Kishida T; Noda T; Izumi Y; Naka K; Okuda K Clin Biochem; 1990 Apr; 23(2):167-71. PubMed ID: 1695557 [TBL] [Abstract][Full Text] [Related]
29. The urinary trypsin inhibitors in some diseases. Nowak S Enzymol Biol Clin (Basel); 1968; 9(1):41-52. PubMed ID: 5652013 [No Abstract] [Full Text] [Related]
30. Pancreatic cellular injury after cardiac surgery with cardiopulmonary bypass: frequency, time course and risk factors. Nys M; Venneman I; Deby-Dupont G; Preiser JC; Vanbelle S; Albert A; Camus G; Damas P; Larbuisson R; Lamy M Shock; 2007 May; 27(5):474-81. PubMed ID: 17438451 [TBL] [Abstract][Full Text] [Related]
31. On the origin of urinary trypsin inhibitor. Aroor AR; Pattabiraman TN Indian J Exp Biol; 1979 May; 17(5):532-3. PubMed ID: 521072 [No Abstract] [Full Text] [Related]
32. [Overall trypsin-like, elastase-like and antitryptic activity in patients with eye contusion]. Bendelik EK; Dotsenko VL; Neshkova EA; Moshetova LK; Iarovaia GA Vopr Med Khim; 1999; 45(4):339-45. PubMed ID: 10547885 [TBL] [Abstract][Full Text] [Related]
33. [Studies on the diagnostic value of trypsin inhibitor in human blood serum. 1. Normal value of trypsin inhibitor capacity and genetic frequency of trypsin inhibitor deficiency in the district Halle of the GDR]. Matzel W; Lindemann I; Reichelt D; Bauer R; Kalbitz B; Krohn C; Khohn W; Mahal KH; Rukhmadi E Dtsch Gesundheitsw; 1973 Feb; 28(8):344-8. PubMed ID: 4704950 [No Abstract] [Full Text] [Related]
35. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)]. Koga S Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605 [TBL] [Abstract][Full Text] [Related]
36. Urinary matrix metalloproteinase -8, -9, -14 and their regulators (TRY-1, TRY-2, TATI) in patients with diabetic nephropathy. Lauhio A; Sorsa T; Srinivas R; Stenman M; Tervahartiala T; Stenman UH; Grönhagen-Riska C; Honkanen E Ann Med; 2008; 40(4):312-20. PubMed ID: 18428024 [TBL] [Abstract][Full Text] [Related]
37. Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum. Paju A; Vartiainen J; Haglund C; Itkonen O; von Boguslawski K; Leminen A; Wahlström T; Stenman UH Clin Cancer Res; 2004 Jul; 10(14):4761-8. PubMed ID: 15269150 [TBL] [Abstract][Full Text] [Related]
38. Recurrent headache as the main symptom of acquired cerebral toxoplasmosis in nonhuman immunodeficiency virus-infected subjects with no lymphadenopathy: the parasite may be responsible for the neurogenic inflammation postulated as a cause of different types of headaches. Prandota J Am J Ther; 2007; 14(1):63-105. PubMed ID: 17303977 [TBL] [Abstract][Full Text] [Related]
39. Trypsin inhibitory capacity in vernal keratoconjunctivitis. Ghavami S; Hashemi M; de Serres FJ; Bajestani SN; Mehrabifar H; Leonardi A Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):264-9. PubMed ID: 17197542 [TBL] [Abstract][Full Text] [Related]
40. Assessment of patients' and physicians' compliance to an ACE inhibitor treatment based on urinary N-acetyl Ser-Asp-Lys-Pro determination in the Noninsulin-Dependent Diabetes, Hypertension, Microalbuminuria, Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) study. Azizi M; Ménard J; Peyrard S; Lièvre M; Marre M; Chatellier G Diabetes Care; 2006 Jun; 29(6):1331-6. PubMed ID: 16732017 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]